(Q38006992)

26 August 2017

Review of the risks and benefits of yellow fever vaccination including some new analyses (English)

1 reference

26 August 2017

0 references

1 reference

1

Thomas P Monath

1 reference

26 August 2017

1 April 2012

1 reference

Expert Review of Vaccines

26 August 2017

1 reference

26 August 2017

11

1 reference

26 August 2017

4

1 reference

26 August 2017

427-448

1 reference

Epidemiology and ecology of yellow fever virus

26 August 2017

1 reference

Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?

21 January 2018

1 reference

Yellow fever vaccines and international travelers

21 January 2018

1 reference

Treatment of yellow fever

21 January 2018

1 reference

VACCINATION AGAINST YELLOW FEVER WITH IMMUNE SERUM AND VIRUS FIXED FOR MICE.

21 January 2018

1 reference

The use of yellow fever virus modified by in vitro cultivation for human immunization

21 January 2018

1 reference

Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection

21 January 2018

1 reference

Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults.

21 January 2018

1 reference

Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial

21 January 2018

1 reference

Yellow fever 17D vaccine safety and immunogenicity in the elderly.

21 January 2018

1 reference

Monitoring adverse events following yellow fever vaccination using an integrated telephone and Internet-based system

21 January 2018

1 reference

The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination

21 January 2018

1 reference

Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever Vaccination

21 January 2018

1 reference

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events

21 January 2018

1 reference

Adverse event reports following yellow fever vaccination

21 January 2018

1 reference

Yellow Fever Vaccine Post-marketing Surveillance in Brazil

21 January 2018

1 reference

Short report: Incidence of yellow fever vaccine-associated neurotropic disease

21 January 2018

1 reference

Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis

21 January 2018

1 reference

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

21 January 2018

1 reference

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

21 January 2018

1 reference

Neurovirulence tests of three 17D yellow fever vaccine strains

21 January 2018

1 reference

Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis

21 January 2018

1 reference

Neuroadapted Yellow Fever Virus 17D: Determinants in the Envelope Protein Govern Neuroinvasiveness for SCID Mice

21 January 2018

1 reference

Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site

21 January 2018

1 reference

Reactions following neurotropic yellow fever vaccine given by scarification in Nigeria

21 January 2018

1 reference

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

21 January 2018

1 reference

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

21 January 2018

1 reference

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

21 January 2018

1 reference

Acute viscerotropic disease following vaccination against yellow fever

21 January 2018

1 reference

Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease

21 January 2018

1 reference

Urban yellow fever epidemic in western Nigeria, 1987.

21 January 2018

1 reference

Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes

21 January 2018

1 reference

Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D.

21 January 2018

1 reference

History of thymoma and yellow fever vaccination

21 January 2018

1 reference

Viscerotropic disease following yellow fever vaccination in Peru

21 January 2018

1 reference

Immune response during adverse events after 17D-derived yellow fever vaccination in Europe

21 January 2018

1 reference

Positional cloning of the murine flavivirus resistance gene

21 January 2018

1 reference

The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells

21 January 2018

1 reference

A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection

21 January 2018

1 reference

Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man

21 January 2018

1 reference

Variability in the 2'-5'-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease.

21 January 2018

1 reference

Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection

21 January 2018

1 reference

CCR5 deficiency increases risk of symptomatic West Nile virus infection

21 January 2018

1 reference

Suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United States

21 January 2018

1 reference

Yellow fever virus vaccine-associated deaths in young women

21 January 2018

1 reference

Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review

21 January 2018

1 reference

Safety of the yellow fever vaccine during the September 2001 mass vaccination campaign in Abidjan, Ivory Coast

21 January 2018

1 reference

Vaccine policy changes and epidemiology of poliomyelitis in the United States

21 January 2018

1 reference

Complications of smallpox vaccination, 1968.

21 January 2018

1 reference

Prevention of yellow fever in persons traveling to the tropics

21 January 2018

1 reference

Spanish travelers to high-risk areas in the tropics: airport survey of travel health knowledge, attitudes, and practices in vaccination and malaria prevention

21 January 2018

1 reference

Travel health knowledge, attitudes and practices among United States travelers

21 January 2018

1 reference

Knowledge, attitudes, and practices of Japanese travelers on infectious disease risks and immunization uptake

21 January 2018

1 reference

The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever

21 January 2018

1 reference

Yellow fever vaccination coverage among children in Brazilian capitals

21 January 2018

1 reference

Anamnestic immune response to dengue and decreased severity of yellow fever

21 January 2018

1 reference

Yellow fever in a Brazilian family returning from vacation in an endemic area: relevant clinical features and epidemiological issues

21 January 2018

1 reference

Yellow fever vaccination and pregnancy: a four-year prospective study

21 January 2018

1 reference

Perinatal transmission of yellow fever, Brazil, 2009.

21 January 2018

1 reference

Congenital yellow fever virus infection after immunization in pregnancy

21 January 2018

1 reference

Yellow fever vaccination during pregnancy and spontaneous abortion: a case-control study

21 January 2018

1 reference

The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil

21 January 2018

1 reference

Early exposure to yellow fever vaccine during pregnancy

21 January 2018

1 reference

Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk

21 January 2018

1 reference

Intra-nasal infection of macaques with Yellow Fever (YF) vaccine strain 17D: a novel and economical approach for YF vaccination in man.

21 January 2018

1 reference

Immunogenicity and tolerability of yellow fever vaccination in 23 French HIV-infected patients

21 January 2018

1 reference

Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients

21 January 2018

1 reference

Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

Detection of yellow fever 17D genome in urine

21 January 2018

1 reference

Factors influencing standard pretravel health advice--a study in Belgium

21 January 2018

1 reference

Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?

21 January 2018

1 reference

Persistence of yellow fever vaccine RNA in urine.

21 January 2018

1 reference

A live, attenuated recombinant West Nile virus vaccine

21 January 2018

1 reference

Persistence of arboviruses and antiviral antibodies in vertebrate hosts: its occurrence and impacts

21 January 2018

1 reference

Persistent Infection with West Nile Virus Years after Initial Infection

21 January 2018

1 reference

Persistent infection and associated nucleotide changes of West Nile virus serially passaged in hamsters

21 January 2018

1 reference

High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production.

21 January 2018

1 reference

Fatal yellow fever contracted at the Hospital for Tropical Diseases, London, UK, in 1930.

21 January 2018

1 reference

Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy

21 January 2018

1 reference

Anaphylaxis from yellow fever vaccine

21 January 2018

1 reference

Multiple evanescent white dot syndrome following simultaneous hepatitis-A and yellow fever vaccination

21 January 2018

1 reference

Vaccination as a triggering event for autoimmune hepatitis

21 January 2018

1 reference

Herpes zoster after yellow fever vaccination.

21 January 2018

1 reference

WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009

21 January 2018

1 reference

Low frequency of side effects following an incidental 25 times concentrated dose of yellow fever vaccine

21 January 2018

1 reference

Is it time for a new yellow fever vaccine?

21 January 2018

1 reference

Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model

21 January 2018

1 reference

Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity

21 January 2018

1 reference

Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies

21 January 2018

1 reference

An inactivated cell-culture vaccine against yellow fever

21 January 2018

1 reference

The need for organization and collaboration: establishing a thymoma registry.

21 January 2018

1 reference

Epidemiology and estimated population burden of selected autoimmune diseases in the United States

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.12.6

1 reference

26 August 2017

1 reference

PubMed ID

22551029